Seoul Pharma Co. Ltd (018680) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.064x

Based on the latest financial reports, Seoul Pharma Co. Ltd (018680) has a cash flow conversion efficiency ratio of -0.064x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.66 Billion ≈ $-1.80 Million USD) by net assets (₩41.30 Billion ≈ $27.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Seoul Pharma Co. Ltd (018680) net asset quality to measure how much of total assets are equity-financed.

Seoul Pharma Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Seoul Pharma Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Seoul Pharma Co. Ltd to evaluate the quality of earnings relative to operating cash generation.

Seoul Pharma Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Seoul Pharma Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
KB SPAC 5 KQ:208350	-0.007x
Giga Media Ltd NASDAQ:GIGM	-0.054x
LL Lucky Games publ AB ST:LADYLU	-0.071x
Shinpoong Pharmaceutical Co Ltd KO:019175	0.022x
Korea Plasma Technology U Co.Ltd KQ:054410	0.004x
Minox International Group Berhad KLSE:0288	0.026x
Garovaglio y Zorraquin S.A. BA:GARO	-0.041x
Labo Print SA WAR:LAB	0.025x

Annual Cash Flow Conversion Efficiency for Seoul Pharma Co. Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Seoul Pharma Co. Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Seoul Pharma Co. Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩40.17 Billion ≈ $27.22 Million	₩-3.01 Billion ≈ $-2.04 Million	-0.075x	-154.86%
2023-12-31	₩38.56 Billion ≈ $26.13 Million	₩5.26 Billion ≈ $3.57 Million	0.137x	+6282.46%
2022-12-31	₩35.42 Billion ≈ $24.00 Million	₩-78.21 Million ≈ $-53.01K	-0.002x	+97.50%
2021-12-31	₩18.96 Billion ≈ $12.85 Million	₩-1.67 Billion ≈ $-1.13 Million	-0.088x	-144.43%
2020-12-31	₩28.85 Billion ≈ $19.55 Million	₩5.74 Billion ≈ $3.89 Million	0.199x	+93.15%
2019-12-31	₩28.45 Billion ≈ $19.28 Million	₩2.93 Billion ≈ $1.98 Million	0.103x	+522.01%
2018-12-31	₩50.31 Billion ≈ $34.10 Million	₩-1.23 Billion ≈ $-831.74K	-0.024x	-15.51%
2017-12-31	₩53.86 Billion ≈ $36.50 Million	₩-1.14 Billion ≈ $-770.77K	-0.021x	+53.00%
2016-12-31	₩42.07 Billion ≈ $28.51 Million	₩-1.89 Billion ≈ $-1.28 Million	-0.045x	-205.98%
2015-12-31	₩33.53 Billion ≈ $22.72 Million	₩1.42 Billion ≈ $963.32K	0.042x	-10.82%
2014-12-31	₩31.10 Billion ≈ $21.08 Million	₩1.48 Billion ≈ $1.00 Million	0.048x	+460.77%
2013-12-31	₩32.25 Billion ≈ $21.86 Million	₩-425.00 Million ≈ $-288.02K	-0.013x	-103.63%
2012-12-31	₩25.38 Billion ≈ $17.20 Million	₩9.22 Billion ≈ $6.25 Million	0.363x	--

About Seoul Pharma Co. Ltd

KQ:018680 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$15.37 Million

₩22.68 Billion KRW

Market Cap Rank

#25887 Global

#1932 in Korea

Share Price

₩1945.00

Change (1 day)

-2.31%

52-Week Range

₩1945.00 - ₩3385.00

All Time High

₩17976.69